Prevention of heterotopic ossification after total hip replacement with NSAIDs

被引:64
作者
Fijn, R
Koorevaar, RT
Brouwers, JRBJ
机构
[1] Univ Groningen Inst Drug Explorat, Groningen Res Inst Pharm GRIP, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands
[3] W Fries Gasthuis, Dept Clin Pharm, Hoorn, Netherlands
[4] Univ Nijmegen Hosp, Dept Orthopaed, NL-6500 HB Nijmegen, Netherlands
[5] Leeuwarden & Tjongerschans Hosp, Dept Clin Pharmacol, Leeuwarden Med Ctr, Heerenveen, Netherlands
[6] Leeuwarden & Tjongerschans Hosp, Dept Hosp Pharm, Leeuwarden Med Ctr, Heerenveen, Netherlands
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 04期
关键词
COX-2; inhibitors; diclofenac; heterotopic ossification (HO); indomethacin; naproxen; non-steroidal; anti-inflammatory drugs (NSAIDs); rofecoxib;
D O I
10.1023/A:1024830213832
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: non steroidal anti-inflammatory drugs ( NSAIDs) and prophylactic radiotherapy can prevent ectopic bone formation around the hip after total hip arthroplasty. Methods: We retrieved from Medline, Embase and the Cochrane Register ( clinical) trials and other relevant literature on the prevention of heterotopic ossification (HO) from 1990-2002 for further review. Results: Review of these clinical trials shows that HO is effectively prevented by a postoperative NSAID treatment with indomethacin for at least seven days. The best evidence is available for indomethacin, although naproxen, diclofenac and ibuprofen are also well documented. Short term use of ibuprofen is not effective. If NSAIDs are contraindicated, preoperative or postoperative radiotherapy is a very effective therapeutic option to prevent HO. Discussion and conclusion: Because of the potential of serious gastrointestinal side effects of NSAIDs and their interaction with anticoagulant drugs, rofecoxib and other COX-2 specific NSAIDs may be a safer option for the treatment of HO. However, randomised controlled studies are needed to confirm the results of the rofecoxib study.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 78 条
[1]   SHORT-TERM IBUPROFEN TO PREVENT OSSIFICATION AFTER HIP-ARTHROPLASTY - NO EFFECTS IN A PROSPECTIVE RANDOMIZED STUDY OF 47 ARTHROSIS CASES [J].
AHRENGART, L ;
BLOMGREN, G ;
TORNKVIST, H .
ACTA ORTHOPAEDICA SCANDINAVICA, 1994, 65 (02) :139-141
[2]  
AHRENGART L, 1991, CLIN ORTHOP RELAT R, V263, P49
[3]   Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty [J].
Amstutz, HC ;
Fowble, VA ;
Schmalzried, TP ;
Dorey, FJ .
JOURNAL OF ARTHROPLASTY, 1997, 12 (02) :126-132
[4]   Prevention of heterotopic bone formation after acetabular fracture fixation by single-dose radiation therapy: A preliminary report [J].
Anglen, JO ;
Moore, KD .
JOURNAL OF ORTHOPAEDIC TRAUMA, 1996, 10 (04) :258-263
[5]  
[Anonymous], COCHRANE DATABASE SY
[6]   INDOMETHACIN AND DISODIUM ETIDRONATE FOR THE PREVENTION OF RECURRENCE OF HETEROTOPIC OSSIFICATION AFTER SURGICAL RESECTION - 2 CASE-REPORTS [J].
BIERINGSORENSEN, F ;
TONDEVOLD, E .
PARAPLEGIA, 1993, 31 (08) :513-515
[7]  
Bontke CF, 1996, J HEAD TRAUMA REHAB, V11, P87
[8]  
BOSSE A, 1996, KLIN AKT TRAUMATOL, V26, P237
[9]  
Bremen-Kuehner R. V., 1997, Zeitschrift fuer Orthopaedie und ihre Grenzgebiete, V135, P422, DOI 10.1055/s-2008-1039411
[10]   Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures [J].
Burd, TA ;
Lowry, KJ ;
Anglen, JO .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2001, 83A (12) :1783-1788